| [回應討論主題 ] | [發起新討論主題 ] | [返回討論板] |
| 發表者 | 討論主題:MRTsAODIjpcOZahxpB | ||
| Ava | 8/26/2014 2:05:53 AM [瞻p穢j]•[穡瓣瞼礎]•[瞼x竄n聶瞻瞼竄] |
|
|
| I'm in my first year at university suhagra price Cubist, known for its Cubicin antibiotic, would gain alate-stage Trius drug that has shown promise in treating skininfections. From Optimer, Cubist will acquire the antibacterial,Dificid, which brought in sales of $19.0 million in the quarterended June. | |||